HBK INVESTMENTS L P Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001011443

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHigh Turnover how tags are computed

Q2 2026 · 234 positions · Total reported value $8.63B · Top-10 concentration 62.8% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 46.4% · 44 new · 31 cut · 54 exited

Active Share (vs S&P 500): 98.3% · vs QQQ: 97.8% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, HBK INVESTMENTS L P disclosed 234 equity positions with a combined reported value of $8.63B. The filing implies a focused portfolio: its ten largest positions account for 62.8% of reported value. HoldingsHub classifies the profile as Mid / Focused / High Turnover.

The largest disclosed positions as of Q2 2026 were BLD ($930.64M), EA ($654.08M), PEN ($580.51M). By sector, the heaviest allocations are Health Care 14.1%, Industrials 13.3%. Versus the prior quarter, allocation shifted toward Health Care (+5.9pp), Technology (+5.9pp) and away from Financials (-1.1pp), Utilities (-1.4pp).

Versus the prior quarter, HBK INVESTMENTS L P opened 44 new positions, trimmed 31 and fully exited 54, a turnover rate of 46.4% of positions. The portfolio's overlap with the prior quarter was 52% of names.

The largest new positions opened in Q2 2026 were BLD ($930.64M), TECH ($482.19M), NUVL ($430.16M).

Of the 54 positions fully exited versus the prior quarter, the largest were HOLX ($740.78M), MASI ($458.21M), CTRA ($371.38M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • BLD TOPBUILD COR · $930.64M
  • TECH BIO-TECHNE CORP · $482.19M
  • NUVL NUVALENT INC · $430.16M
  • APGE APOGEE THERAPEUTICS INC · $378.28M
  • SLAB SILICON LABORATORIES INC · $218.56M
  • ROKU ROKU INC · $163.60M
  • AES AES CORP · $162.30M
  • VAL VALARIS LTD · $114.36M

Fully Exited (vs previous quarter)

  • HOLX HOLOGIC IN · prev qtr: $740.78M
  • MASI MASIMO CORP · prev qtr: $458.21M
  • CTRA COTERRA EN · prev qtr: $371.38M
  • AL AIR LEASE CORP · prev qtr: $358.94M
  • CWAN CLEARWATER ANALYTICS HLDGS I · prev qtr: $328.14M
  • SEE SEALED AIR CORP NEW · prev qtr: $307.19M
  • ACLX ARCELLX IN · prev qtr: $261.62M
  • TERN TERNS PHARMACEUTICALS INC · prev qtr: $155.52M

Insider Transactions (Form 4)

Latest HBK INVESTMENTS L P buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

HBK Investments, L.P. is a Dallas-based investment firm founded by Howard "Howie" Berkowitz in 1998, employing a long/short equity strategy focused on US equities.

Investment Approach

Fundamental, bottom-up research methodology

Focus on identifying undervalued and overvalued companies

Long positions in undervalued stocks, short positions in overvalued stocks

Strategy/Asset Classes

Primarily focused on US equities

Long/short equity strategy

May also include other asset classes but primarily equities

Notable Facts

Founded in 1998

AUM of approximately $35.6 billion (per SEC Form ADV)

Files Form 13F with SEC, tracking US equity positions

Key People

Howard "Howie" Berkowitz: Founder and Portfolio Manager

This profile is based on publicly available information; please refer to official SEC filings for the most current and accurate data.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund appears to be taking a proactive approach to diversification and seeking growth opportunities in various sectors. The increase in new positions suggests a belief in the potential of these sectors to outperform, with a particular interest in technology and health care. 2. Key Moves: - New Positions: Added positions in BIO-TECHNE CORP (TECH), NUVALENT INC (NUVL), APOGEE THERAPEUTICS INC (APGE), and TOPBUILD CORP (BLD). - Reduction: Reduced position in ELECTRONIC ARTS INC (EA) by 3.19 million shares. - Increase: Increased positions in PENUMBRA INC (PEN), NORFOLK SOUTHN CORP (NSC), KENVUE INC (KVUE), WARNER BROS DISCOVERY INC (WBD), and CHART INDUSTRIES INC (GTLS). 3. Portfolio Structure: The fund seems to be active, with a balanced approach to sector allocation. It exhibits a bias towards technology and health care, sectors that are known for innovation and growth potential. The risk appetite is moderate, as indicated by the diversification across various sectors and the addition of new positions in both established and emerging companies. 4. Per-Holding One-Liner: - BLD: TOPBUILD CORP - Construction and engineering services. - EA: ELECTRONIC ARTS INC - Interactive entertainment software and services. - PEN: PENUMBRA INC - Health care information technology. - NSC: NORFOLK SOUTHN CORP - Utility company. - KVUE: KENVUE INC - Home improvement retailer. - WBD: WARNER BROS DISCOVERY INC - Media and entertainment. - TECH: BIO-TECHNE CORP - Life sciences and diagnostics. - NUVL: NUVALENT INC - Life sciences and diagnostics. - APGE: APOGEE THERAPEUTICS INC - Biotechnology and pharmaceuticals. - GTLS: CHART INDUSTRIES INC - Aerospace and defense equipment manufacturing. ('unverified') 5. One-Sentence Style Summary: HBK Investments LP is actively diversifying its portfolio with a focus on growth sectors like technology and health care, adding new positions while trimming select holdings in entertainment and utilities.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 14.1%
Industrials 13.3%
Technology 7.4%
Financials 3.2%
Energy 1.5%
Other 43.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.62M $930.64M 10.79%
10.79%
New
2 3.19M $654.08M 7.58%
7.58%
Reduce
3 1.84M $580.51M 6.73%
6.73%
Add
4 1.75M $550.53M 6.38%
6.38%
Add
5 28.00M $535.08M 6.20%
6.20%
Add
6 18.97M $505.63M 5.86%
5.86%
Add
7 6.83M $482.19M 5.59%
5.59%
New
8 3.48M $430.16M 4.99%
4.99%
New
9 2.85M $378.28M 4.39%
4.39%
New
10 1.79M $373.81M 4.33%
4.33%
Add
11 5.77M $343.27M 3.98%
3.98%
Add
12 5.15M $267.76M 3.10%
3.10%
Add
13 1.00M $218.56M 2.53%
2.53%
New
14 1.03M $205.97M 2.39%
2.39%
Add
15 1.18M $163.60M 1.90%
1.90%
New
16 11.07M $162.30M 1.88%
1.88%
New
17 4.50M $149.51M 1.73%
1.73%
Add
18 1.58M $114.36M 1.33%
1.33%
New
19 397.20K $109.69M 1.27%
1.27%
Add
20 2.82M $88.64M 1.03%
1.03%
New
21 1.48M $59.13M 0.69%
0.69%
New
22 350.00K $40.96M 0.47%
0.47%
Add
23 237.50K $40.58M 0.47%
0.47%
New
24 1.97M $38.28M 0.44%
0.44%
Hold
25 162.20K $35.35M 0.41%
0.41%
New
26 21.50M $34.78M 0.40%
0.40%
Add
27 441.65K $31.67M 0.37%
0.37%
New
28 1.04M $31.08M 0.36%
0.36%
Add
29 28.20M $30.25M 0.35%
0.35%
Add
30 388.02K $29.94M 0.35%
0.35%
Hold
31 1.18M $29.39M 0.34%
0.34%
Hold
32 484.94K $27.53M 0.32%
0.32%
Reduce
33 20.15M $26.12M 0.30%
0.30%
Hold
34 937.00K $23.00M 0.27%
0.27%
Reduce
35 773.40K $22.85M 0.27%
0.27%
Add
36 52.80K $22.21M 0.26%
0.26%
Add
37 82.00K $22.05M 0.26%
0.26%
Reduce
38 50.00K $19.70M 0.23%
0.23%
Hold
39 8.00M $19.51M 0.23%
0.23%
Hold
40 1.30M $18.04M 0.21%
0.21%
Hold
41 14.89M $17.86M 0.21%
0.21%
Hold
42 16.50M $16.25M 0.19%
0.19%
Hold
43 13.70M $16.17M 0.19%
0.19%
Add
44 980.01K $15.43M 0.18%
0.18%
Reduce
45 10.00M $15.35M 0.18%
0.18%
Hold
46 156.90K $14.70M 0.17%
0.17%
Add
47 179.46K $14.67M 0.17%
0.17%
New
48 155.19K $14.50M 0.17%
0.17%
New
49 343.71K $14.44M 0.17%
0.17%
New
50 80.00K $14.37M 0.17%
0.17%
Add

FAQ

What did HBK INVESTMENTS L P buy in 2026-Q2?

In its 2026-Q2 13F filing, HBK INVESTMENTS L P reported 234 equity positions worth $8.63B in aggregate; its largest disclosed positions were BLD ($930.64M), EA ($654.08M), PEN ($580.51M).

How large is HBK INVESTMENTS L P's portfolio?

HBK INVESTMENTS L P reported $8.63B of long equity holdings across 234 positions as of 2026-Q2. Top-10 holdings account for 62.8% of reported value.

What is HBK INVESTMENTS L P's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/hbk-investments-l-p/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →